FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE - Patent 2997383

(19)

(11)

EP 2 997 383 A1

(12)

(43)	Date of publication:
	23.03.2016 Bulletin 2016/12

(21)	Application number: 14725123.5

(22)	Date of filing: 16.05.2014

(51)

International Patent Classification (IPC):

G01N 33/74^(2006.01)

(86)	International application number:
	PCT/EP2014/060052

(87)	International publication number:
	WO 2014/184334 (20.11.2014 Gazette 2014/47)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

16.05.2013 EP 13305627

(71)	Applicants:
	INSERM (Institut National de la Santé et de la Recherche Médicale) 75013 Paris (FR) Université Paris Descartes 75006 Paris (FR) Assistance Publique-Hôpitaux de Paris (APHP) 75004 Paris (FR)

(72)	Inventors:
	FRIEDLANDER, Gérard F-75993 Paris Cedex 14 (FR) PRIE, Dominique F-75993 Paris Cedex 14 (FR)

(74)	Representative: Collin, Matthieu
	Inserm-Transfert Paris Biopark 7, rue Watt 75013 Paris 75013 Paris (FR)

(54)	FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE